Presented by Pathfinder International
After years of decline, cholera is on the rise — and experts chalk this increase up to climate change as waters warm and violent weather becomes the norm.
Twenty-nine countries have reported cases of cholera already this year — some of which, such as Haiti, Syria, and Lebanon, haven't seen an outbreak in years. Over the past five years, an average of less than 20 countries reported outbreaks per year. Furthermore, the average case fatality rate this year is nearly three times the rate seen during the past five years.
This is a preview of Devex CheckUp
Sign up to this newsletter for exclusive global health news and insider insights, in your inbox every Thursday.
“We've seen a dramatic increase in the number of cases of cholera,” UNICEF health specialist Raoul Kamadjeu tells Sara, echoing the words of World Health Organization chief Tedros Adhanom Ghebreyesus, who said cholera was being “turbocharged by climate change.”
• It’s a water-borne disease, and populations of cholera-causing bacteria increase as water temperatures rise. Floods, monsoons, cyclones, and hurricanes stir up sediment and contaminate water. They also destroy water and sanitation infrastructure — often leeching sewage into the water. When there is drought, people are often left with only sediment-rich, contaminated water.
• These weather events spur widespread migration. Displacement camps are often crowded with inadequate sanitation — becoming breeding grounds for cholera. And because of the uptick in cases, demand is so high for cholera vaccines that WHO and its partners said there aren’t enough, so it lowered the recommended doses from two to one to broaden access.
• Cholera is particularly dangerous for malnourished children. "If they get cholera and don't go directly to the health center, they will die in hours," says IFRC’s Alexandra Machado.
Read: Cholera thrives in a warming world
+ For more climate change news, check out our Road to COP 27 series. Also, before COP 27, join Devex and a panel of experts to get ahead of the discussions and hear about the key issues to watch. Register now.
Penny pinching
The Financial Intermediary Fund for Pandemic Prevention, Preparedness and Response is underfunded — by a lot, our colleague Shabtai Gold writes. Donors have given just $1.4 billion of the $10.5 billion it needs annually. It's a trust fund that pools public and private money to prevent, prepare for, and respond to future pandemics. While the intention was that countries would allocate new money to this fund, there is a temptation for high-income governments to just move funds around within existing budgets, according to Center for Global Development’s Peter Barker.
Read: The pandemic readiness fund is short on cash. It's not the only issue. (Pro)
+ Not yet a Devex Pro member? Sign up for a free 15-day trial of Pro to access this story.
Somalia deteriorating
“The warning signs of this crisis have been clear for at least the past year, but funds have not come in time for too many.”
—Awil Abukar Mohamed, senior media and communication officer, Islamic Relief SomaliaIn Somalia’s devastating drought, child mortality has increased significantly, Mohamed writes in an op-ed for Devex. More than 700 children have died in official nutrition centers — but that’s an underestimate, as many deaths are undocumented.
“In the camps, I met young children so malnourished and weak that they could barely stand. Some had not eaten for days or had survived on a diet of wild fruits that are not usually fit for humans to eat,” Mohamed writes.
Opinion: Somalia needs the world to wake up now
ICYMI: Sara visited drought-impacted communities in Mogadishu and Baidoa, Somalia in late August, when the situation was already dire. She also reported on the politics surrounding a famine declaration — and why the world shouldn’t wait for one before pumping in resources.
Upcoming events
EGYPT
COP27 Health Pavilion
Nov. 6-18
GERMANY
15th European Public Health Conference 2022
Nov. 9-12
KENYA
IQVIA Africa Health Summit
Nov. 16-17
SOUTH AFRICA
The Global Health Network Conference
Nov. 24-25
Getting their ACT-A together
Last month, we reported the transition plan for Access to COVID-19 Tools Accelerator, or ACT-A, will be out soon. We now know that it is expected to be announced tomorrow. Here are some questions we have in the meantime:
• “The ACT Accelerator has to change,” WHO’s Dr. Bruce Aylward, who coordinates the work of ACT-A, told our colleague Jenny Lei Ravelo. Aylward said that the initiative also plans to increase procurement and access to treatments. Will there be new structures put in place, and how will funding be organized?
• Aylward also said that the work of partner organizations, including Gavi, Unitaid, and the Global Fund might change over time. How will this be coordinated across agencies?
• In a separate interview, Dr. Ayoade Alakija, the WHO special envoy for ACT-A, told us that one of the key weaknesses of the initiative was poor communication that led to inequity. How will the transition plan tackle this?
• Earlier this month, two-thirds of the respondents of an independent evaluation felt that the ACT-A model should not be replicated — does the new plan address this concern?
Don’t miss our analysis of ACT-A’s transition plan in tomorrow’s Newswire. Sign up now to receive it.
Gates way
$8,589,796
—That’s how much money the Bill & Melinda Gates Foundation gave to the Institut Pasteur de Dakar to fund the technology transfer needed to manufacture measles and rubella vaccines for routine immunization campaigns in low- and middle-income countries.
The technology transfer will take one year and then production for trials and submission for regulatory approvals will commence, Dr. Joe Fitchett, senior adviser for biotechnology at the institute, tells Sara.
ICYMI: Senegal nears completion of 'bespoke' vaccine manufacturing facility (Pro)
Mushrooming problem
Your next job?
Individual Consultant: Geographic Health Information System (GIS) Project
United Nations Development Programme
Kiribati/Remote
WHO released its first list of 19 fungi that most threaten human health. Fungal pathogens are becoming more common and resistant to treatment, but there are only four classes of antifungal medicines on the market and a slim pipeline for new ones.
What we’re reading
We may only have a few months to prevent the next pandemic, writes one doctor with experience battling epidemics. [The New York Times]
Merck says it has located a frozen batch of undisclosed Ebola vaccine, which will be donated for testing in Uganda’s outbreak. [Science]
Extreme flooding and other climate-related disasters are leading to explosive disease outbreaks. [Scientific American]